Literature DB >> 28079746

Sentinel Surveillance for Expedited Partner Therapy Prescriptions Using Pharmacy Data, in 2 New York City Neighborhoods, 2015.

Ebiere Okah1, Vibhuti Arya, Meighan Rogers, Michelle Kim, Julia Ann Schillinger.   

Abstract

BACKGROUND: Expedited partner therapy (EPT) for Chlamydia trachomatis (Ct) is the practice of providing Ct-infected patients with medication, or prescription (prescription-EPT) to deliver to their sex partners without first examining those partners. New York City (NYC) providers commonly use prescription-EPT, yet NYC pharmacists report only occasional receipt of EPT prescriptions. This project assessed the frequency of EPT prescriptions filled in 2 NYC neighborhoods.
METHODS: The 2 NYC facilities reporting the most frequent use of prescription-EPT were identified from Ct provider case reports and contacted to ascertain their EPT practices. Providers at the first facility (facility 1) prescribed two 1-g doses of azithromycin, including sex partner treatment on the index patient's electronic prescription. Providers at the second facility (facility 2) gave patients paper prescriptions for sex partners. We reviewed prescriptions filled in 2015 for azithromycin, 1 or 2 g at pharmacies near these facilities; prescriptions indicating partner therapy were classified "EPT prescriptions".
RESULTS: Facility 1 providers submitted 112 Ct case reports indicating prescription-EPT, compared with 114 submitted by facility 2 providers. Twelve of 26 identified pharmacies agreed to participate. At 7 pharmacies near facility 1, we found 61 EPT prescriptions from facility 1 and 37 from other facilities. At 5 pharmacies near facility 2, we found only 1 EPT prescription from facility 2 and 3 from other facilities.
CONCLUSIONS: Expedited partner therapy prescriptions were received in NYC pharmacies near to EPT-prescribing facilities, but with great variability and at a lower frequency than suggested by provider case reports. Provider EPT prescribing practices may impact the likelihood that partners receive medication and should be further evaluated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28079746     DOI: 10.1097/OLQ.0000000000000551

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  4 in total

1.  The Challenges of Implementing and Evaluating Prescription Expedited Partner Treatment.

Authors:  Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-02       Impact factor: 2.830

Review 2.  Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019.

Authors:  Sarah J Willis; Noelle M Cocoros; Liisa M Randall; Aileen M Ochoa; Gillian Haney; Katherine K Hsu; Alfred DeMaria; Michael Klompas
Journal:  Curr Infect Dis Rep       Date:  2019-08-26       Impact factor: 3.725

3.  Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy.

Authors:  Cornelius D Jamison; Jenell S Coleman; Okeoma Mmeje
Journal:  Obstet Gynecol       Date:  2019-03       Impact factor: 7.661

4.  Partner notification and partner treatment for chlamydia: attitude and practice of general practitioners in the Netherlands; a landscape analysis.

Authors:  Ingrid V F van den Broek; Gé A Donker; Karin Hek; Jan E A M van Bergen; Birgit H B van Benthem; Hannelore M Götz
Journal:  BMC Fam Pract       Date:  2017-12-20       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.